Topic: Food and Drug Administration
WASHINGTON (Reuters) - A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market. Final data from the so-called SCOUT ...
WASHINGTON (Reuters) - A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market. Final data from the so-called SCOUT ...
Medical filters that stop blood clots from reaching the lungs can move or break and cause life-threatening problems for patients, the government and a medical journal report said Monday. In an advisory to doctors and patients, the Food and Drug Administration said ...
ADELPHI, Maryland (Reuters) - U.S. advisers backed a potential blockbuster blood thinner from AstraZeneca on Wednesday, a victory for a company seeking new drugs to offset expiring patents on some of its best-selling medicines. Members of a Food and Drug Administration panel ...
Shares of obesity drug developers rise following study on Arena Pharmaceuticals' lorcaserinShares of obesity drug developers rose Thursday following a report that Arena Pharmaceuticals Inc.'s lorcaserin prompted weight loss without heart-related side effects. On Wednesday, a study showed that lorcaserin caused more ...
A majority of members of a key advisory committee recommended Wednesday that the US government allow diabetes drug Avandia to stay on the market with greater restrictions on its sale. Most of the panel's members agreed that the drug does increase the ...
Experimental diet pill promising, with fewer health risks; one of 3 awaiting FDA approvalAn experimental diet pill helped about half the people who tried it lose some weight and keep it off a year later, without the heart problems that some earlier ...
FDA panel says Avandia should stay on market despite evidence of heart risksA majority of federal health experts voted Wednesday to keep the controversial diabetes pill Avandia on the market despite evidence that it increases the risk of heart attack. A panel ...
Controversial diabetes drug Avandia does increase the risk of heart problems, a key panel of experts charged with deciding whether to pull the drug from the US markets said Wednesday. Nineteen of the 33 members on the panel convened by the Food ...
WASHINGTON (Reuters) - Clinical trials aimed at pinpointing emerging safety problems with drugs already on the market should only be conducted when other, less invasive research is not possible, a U.S. advisory group said on Friday. The Institute of Medicine's report, requested ...
Photo Gallery
-
Allergan Settlement
Food and Drug Administration (FDA) Commissioner Margaret Hamburg, center, with Assistant Attorney ...AP News - -
US Allergan Settlement
Food and Drug Administration (FDA) Commissioner Margaret Hamburg speaks to reporters during ...AP News - -
Cymbalta FDA Review
FILE - In this Jan. 25, 2006 file photo, a production technician at ...AP News -
From Around the Web
Video Gallery
-
Why the Food And Drug Administration ...
The FDA suppresses natural cures because if you're not ...2007-07-19 -
4409 -- FDA employee admits Aspartame is ...
www.Formula4409.com Help this channel by posting this link ...2010-02-11 -
Simpleton's Guide: The Food and ...
Professor Scammington speaks to the relative evils of the Food ...2007-12-14
